Review article · 2024
Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer
Molecular Pharmaceutics, 21(12), 5960–5988 · Published 19 November 2024 · DOI 10.1021/acs.molpharmaceut.4c00801
In brief
“Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer” is a 2024 review article by Sreejith Thrivikraman Nair and 7 co-authors, published in Molecular Pharmaceutics. OpenAlex counts 18 citations as of 21 November 2026, which puts it in the top 2% of works published in 2024 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 18
- Most cited in
- 2026 (12)
- Field-weighted impact
- 0.40
- References
- 250
- Authors
- 8
Abstract
Tumor heterogeneity poses a significant challenge in cancer therapy. To address this, we analyze pharmacotherapeutic challenges by categorizing them into static and dynamic barriers, reframing these challenges to improve drug delivery, efficacy, and the development of controlled-release nanomedicines (CRNMs). This pathophysiology-driven approach facilitates the design of novel therapeutics tailored to overcome obstacles in pancreatic ductal… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Nair, S. T., Abhi, C., Kamalasanan, K., Pavithran, K., Unni, A. R., Sithara, M. S., Sarma, M., & Mangalanandan, T. S. (2024). Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer. Molecular Pharmaceutics, 21(12), 5960–5988. https://doi.org/10.1021/acs.molpharmaceut.4c00801
MLA 9
Nair, Sreejith Thrivikraman, et al. “Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer.” Molecular Pharmaceutics, vol. 21, no. 12, 2024, pp. 5960–5988. https://doi.org/10.1021/acs.molpharmaceut.4c00801.
Chicago
Nair, Sreejith Thrivikraman, C Abhi, Kaladhar Kamalasanan, Keechilat Pavithran, Ashok R Unni, M S Sithara, Manjit Sarma, and Thacho Sukumaran Mangalanandan. 2024. “Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer.” Molecular Pharmaceutics 21 (12): 5960–5988. https://doi.org/10.1021/acs.molpharmaceut.4c00801.
Harvard
Nair, S. T. et al. (2024) ‘Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer’, Molecular Pharmaceutics, 21(12), pp. 5960–5988. doi:10.1021/acs.molpharmaceut.4c00801.
IEEE
S. T. Nair et al., “Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer,” Molecular Pharmaceutics, vol. 21, no. 12, pp. 5960–5988, 2024, doi: 10.1021/acs.molpharmaceut.4c00801.
BibTeX
@article{nair2024pathophysiology,
title = {{Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer}},
author = {Nair, Sreejith Thrivikraman and Abhi, C and Kamalasanan, Kaladhar and Pavithran, Keechilat and Unni, Ashok R and Sithara, M S and Sarma, Manjit and Mangalanandan, Thacho Sukumaran},
journal = {Molecular Pharmaceutics},
year = {2024},
volume = {21},
number = {12},
pages = {5960--5988},
doi = {10.1021/acs.molpharmaceut.4c00801},
url = {https://doi.org/10.1021/acs.molpharmaceut.4c00801}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- pancreatic ductal adenocarcinoma
- tumor heterogeneity
- drug delivery barriers
- nanoparticle drug delivery
- RNA interference
- evofosfamide
- Notch signaling
- Hedgehog signaling
Work with this paper
Most-cited papers in Materials Science
- Electric Field Effect in Atomically Thin Carbon FilmsKostya S. Novoselov, Andre K. Geim, Sergey V. Morozov and 5 more · Science · 2004 · 67,474 citations
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesROBERT D. SHANNON · Acta Crystallographica Section A · 1976 · 66,944 citations
- Ab initio molecular dynamics for liquid metalsGeorg Kresse, J. Häfner · Physical review. B, Condensed matter · 1993 · 46,320 citations
- Helical microtubules of graphitic carbonSumio Iijima · Nature · 1991 · 43,639 citations
- The rise of grapheneAndre K. Geim, Kostya S. Novoselov · Nature Materials · 2007 · 40,328 citations
Questions about this paper
How do I cite this paper in APA style?
Nair, S. T., Abhi, C., Kamalasanan, K., Pavithran, K., Unni, A. R., Sithara, M. S., Sarma, M., & Mangalanandan, T. S. (2024). Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer. Molecular Pharmaceutics, 21(12), 5960–5988. https://doi.org/10.1021/acs.molpharmaceut.4c00801
How many times has this paper been cited?
18 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Sreejith Thrivikraman Nair, C Abhi, Kaladhar Kamalasanan, Keechilat Pavithran, Ashok R Unni, M S Sithara, Manjit Sarma, Thacho Sukumaran Mangalanandan.
What is the DOI of this paper?
10.1021/acs.molpharmaceut.4c00801, permanently at https://doi.org/10.1021/acs.molpharmaceut.4c00801. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.